Last reviewed · How we verify
Rifaximin Novel Formulation
At a glance
| Generic name | Rifaximin Novel Formulation |
|---|
| Sponsor | Bausch Health Americas, Inc. |
|---|
| Modality | Small molecule |
|---|
| Phase | Phase 1 |
|---|
Approved indications
No approved indications tracked.
Common side effects
No common side effects on file.
Key clinical trials
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.